Mohammad Alzrigat
- Hematology top 10%
- Multiple Myeloma Research and Treatments 5
-
- Cancer, Hypoxia, and Metabolism 2
-
- Histone Deacetylase Inhibitors Research 6
- Protein Degradation and Inhibitors 5
- Epigenetics and DNA Methylation 4
-
- Immune Cell Function and Interaction 3
-
- Peptidase Inhibition and Analysis 2
-
- Neuroblastoma Research and Treatments 2
- Co-authors
- Helena Jernberg‐WiklundAnqi MaFredrik ÖbergJian JinAntonia KalushkovaKenneth NilssonPrasoon AgarwalAnders Österborg
- Journals
- Nature Communications (1 paper)The Journal of Cell Biology (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- SwedenUnited StatesCanada
In The Last Decade
Mohammad Alzrigat
14 papers receiving 315 citations
Peers
Comparison fields: 5 of 45
- Hematology 122
- Cancer Research 60
- Molecular Biology 260
- Immunology 42
- Oncology 42
Countries citing papers authored by Mohammad Alzrigat
This map shows the geographic impact of Mohammad Alzrigat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Alzrigat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Alzrigat more than expected).
Fields of papers citing papers by Mohammad Alzrigat
This network shows the impact of papers produced by Mohammad Alzrigat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Alzrigat. The network helps show where Mohammad Alzrigat may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammad Alzrigat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 15 | |
| 7 | 2021 | 5 | |
| 8 | 2020 | 9 | |
| 9 | 2018 | 18 | |
| 10 | 2017 | 66 | |
| 11 | 2017 | 19 | |
| 12 | 2017 | 17 | |
| 13 | 2016 | 46 | |
| 14 | 2016 | 60 | |
| 15 | 2012 | 49 |
About Mohammad Alzrigat
Mohammad Alzrigat is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 15 papers that have together received 317 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (6 papers), Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (5 papers), Epigenetics and DNA Methylation (4 papers), Immune Cell Function and Interaction (3 papers), Peptidase Inhibition and Analysis (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Hematology (122 citations), Cancer Research (60 citations) and Molecular Biology (260 citations). Mohammad Alzrigat has collaborated with scholars based in Sweden, United States and Canada. Frequent co-authors include Helena Jernberg‐Wiklund, Anqi Ma, Fredrik Öberg, Jian Jin, Antonia Kalushkova, Kenneth Nilsson, Prasoon Agarwal, Anders Österborg, Jonathan D. Licht and Thomas Stamminger. Their work appears in journals such as Nature Communications, The Journal of Cell Biology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.